LEP and metabolic dysfunction-associated steatohepatitis: Conversely, another study has suggested that BA safeguards against diet-induced NASH and liver fibrosis in LDLR-/-*Leiden mice by rectifying hyperinsulinemia, reducing plasma leptin levels, and alleviating adipose tissue inflammation, without influencing gut permeability or microbiota composition [43].